Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 110Head and Neck Neoplasms 97Nasopharyngeal Carcinoma 36Carcinoma, Non-Small-Cell Lung 21Salivary Gland Neoplasms 17Carcinoma, Squamous Cell 14Laryngeal Neoplasms 12Nasopharyngeal Neoplasms 10Melanoma 10Breast Neoplasms 10Oropharyngeal Neoplasms 9Hypopharyngeal Neoplasms 9Stomach Neoplasms 8Neoplasms 8Esthesioneuroblastoma, Olfactory 8Esophageal Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 7Carcinoma, Renal Cell 7Urinary Bladder Neoplasms 6Tongue Neoplasms 6Small Cell Lung Carcinoma 6Recurrence 6Lung Neoplasms 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Mouth Neoplasms 4

Interventions

Fulvestrant 2Alpelisib 2tipifarnib 1ribociclib 1palbociclib 1exemestane 1abemaciclib 1Tamoxifen 1STX-478 1SF 1126 1Panobinostat 1PX-866 1Metformin 1Letrozole 1Imlunestrant 1Everolimus 1Docetaxel 1Cetuximab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Docetaxel × Head & Neck × Clear all
NCT01204099 2018-05-16

Study of PX-866 and Docetaxel in Solid Tumors

Seagen Inc.

Phase 1/2 Completed
223 enrolled
Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡